Evidence map›Paper›PMID 23926098›Full record

ArticleThe Journal of biological chemistry2013

Non-targeted identification of prions and amyloid-forming proteins from yeast and mammalian cells.

Dmitry Kryndushkin, Natalia Pripuzova, Barrington G Burnett, Frank Shewmaker

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Genes near tRNAs are enriched in translational machinery.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Overexpression inFrontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Article
  9. Effect of the aggregated protein dye YAT2150 onAntimicrobial agents and chemotherapy · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Protein aggregation and the evolution of stress resistance in clinical yeast.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Article
  14. Article
  15. Review
  16. Detection of Protein Aggregation in LiveAntimicrobial agents and chemotherapy · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dmitry KryndushkinDepartment of Pharmacology. Electronic address: dkrynd@yahoo.com.
Natalia PripuzovaDivision of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892.
Barrington G BurnettDepartment of Anatomy, Physiology, and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
Frank ShewmakerDepartment of Pharmacology. Electronic address: frank.shewmaker@usuhs.edu.
Center for Biologics Evaluation and Research · USUniformed Services University of the Health Sciences · US

Funding

Molecular library screen for suppressors of FUS proteinopathyR03DA035194 · NIDA · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SHEWMAKER, FRANK P · 2012 to 2013
$71k
NIDA NIH HHS 1R03DA035194NIDA NIH HHS R03 DA035194
6 · The paper itself

Abstract

The formation of amyloid aggregates is implicated both as a primary cause of cellular degeneration in multiple human diseases and as a functional mechanism for providing extraordinary strength to large protein assemblies. The recent identification and characterization of several amyloid proteins from diverse organisms argues that the amyloid phenomenon is widespread in nature. Yet identifying new amyloid-forming proteins usually requires a priori knowledge of specific candidates. Amyloid fibers can resist heat, pressure, proteolysis, and denaturation by reagents such as urea or sodium dodecyl sulfate. Here we show that these properties can be exploited to identify naturally occurring amyloid-forming proteins directly from cell lysates. This proteomic-based approach utilizes a novel purification of amyloid aggregates followed by identification by mass spectrometry without the requirement for special genetic tools. We have validated this technique by blind identification of three amyloid-based yeast prions from laboratory and wild strains and disease-related polyglutamine proteins expressed in both yeast and mammalian cells. Furthermore, we found that polyglutamine aggregates specifically recruit some stress granule components, revealing a possible mechanism of toxicity. Therefore, core amyloid-forming proteins as well as strongly associated proteins can be identified directly from cells of diverse origin.

Indexed as

AmyloidPeptidesPrionsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAnimalsHumansPC12 CellsProteomicsRatsSodium Dodecyl SulfateUreaAmyloidPeptidespolyglutaminePrionsSaccharomyces cerevisiae ProteinsSodium Dodecyl SulfateUreaAggregationAmyloidFUSMass Spectrometry (MS)PolyglutaminePrionsrnq1Stress Granulesup35Yeast

Identifiers

PMID23926098
PMCPMC3779709
OpenAlexW2092370871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.